Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
基本信息
- 批准号:10686076
- 负责人:
- 金额:$ 26.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocacyAgeAutosomal Dominant Polycystic KidneyBeliefBiological MarkersBiomedical ResearchBlood specimenCaregiversClinical ResearchClinical TrialsClinical Trials NetworkCollectionCommon Data ElementCommunitiesComputer softwareConsensusData CollectionData SourcesDatabasesDevelopmentDiseaseDisease ProgressionDisease modelEnrollmentEnvironmentFamilyFamily memberFunctional disorderGoalsHealth PersonnelHealthcareIndividualIndustryInfrastructureInternationalKansasLongitudinal cohortMapsNatural HistoryOutcomeOutcome MeasurePatient-Focused OutcomesPatientsPharmacotherapyPhenotypePrognostic MarkerProtocols documentationRaceRegistriesResearchResearch PersonnelResearch PriorityResourcesRiskSiteSourceStandardizationTerminologyTranslatingTranslationsUpdateUrineWorkbiomarker discoveryclinical developmentcohortcompare effectivenessdata formatdata harmonizationdata integrationdata modelingdata standardsdesigndiverse dataempowermentexosomeexperienceinformation gatheringinstrumentmultiple data sourcesnovelnovel therapeuticspatient engagementpatient orientedpreferenceprogramsrecruitshared decision makingsocioeconomicstolvaptantooltranslational pipelinetrial designtrial readinessurinary
项目摘要
Clinical Research Core - Project Summary/Abstract
The overarching challenge in PKD is how to translate the many advances in basic scientific understanding of
the pathophysiology of PKD into the development of effective new drugs. Specific challenges include a
shrinking pool of patients available for clinical trials, lack of biomarkers in early disease, lack of widely-
available, standardized data models to harmonize diverse data sources, and limited engagement of patients
and their families in prioritizing research questions. The goal of the Clinical Research Core is to facilitate
research across the translational spectrum from T1 to T4 by PKD investigators nationwide. This will be
achieved through the development of multiple tools and resources that will be made freely available to the
research community. The specific aims are: 1) to create a consortium of academic centers across the Central
and Western regions to form an ADPKD clinical trial network; 2) to expand and continue to follow a longitudinal
cohort of young patients with early ADPKD and control subjects and collect biospecimens for biomarker
discovery; 3) create a standardized data collection instrument for PKD studies in RedCAP and software for
automated mapping into a standard data format required for registration studies; and 4) use our patient
engagement resource to identify patients' priorities for research questions and use this to inform research
strategy and directions in the PKD community.
临床研究核心 - 项目摘要/摘要
PKD 的首要挑战是如何将基础科学理解中的许多进步转化为
将 PKD 的病理生理学转化为有效新药的开发。具体挑战包括
可用于临床试验的患者数量不断减少,缺乏早期疾病的生物标志物,缺乏广泛的
可用的标准化数据模型来协调不同的数据源,并且患者的参与有限
和他们的家人优先考虑研究问题。临床研究核心的目标是促进
全国 PKD 研究人员进行从 T1 到 T4 的转化谱研究。这将是
通过开发多种工具和资源来实现,这些工具和资源将免费提供给
研究社区。具体目标是:1)创建一个跨中央的学术中心联盟
与西部地区组建ADPKD临床试验网络; 2)扩大并继续沿纵向
早期 ADPKD 年轻患者和对照受试者队列并收集生物样本作为生物标志物
发现; 3) 在 RedCAP 和软件中创建用于 PKD 研究的标准化数据收集工具
自动映射为注册研究所需的标准数据格式; 4)使用我们的病人
参与资源,以确定患者对研究问题的优先顺序,并利用其为研究提供信息
PKD 社区的战略和方向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan S Yu其他文献
Alan S Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan S Yu', 18)}}的其他基金
Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
- 批准号:
10475048 - 财政年份:2020
- 资助金额:
$ 26.65万 - 项目类别:
Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
- 批准号:
10059768 - 财政年份:2020
- 资助金额:
$ 26.65万 - 项目类别:
Biomedical Research Core 3 - Clinical Research Core
生物医学研究核心 3 - 临床研究核心
- 批准号:
10214616 - 财政年份:2020
- 资助金额:
$ 26.65万 - 项目类别:
Role of claudin-2 in Calcium Homeostasis and Kidney Stone Disease
Claudin-2 在钙稳态和肾结石疾病中的作用
- 批准号:
10238078 - 财政年份:2019
- 资助金额:
$ 26.65万 - 项目类别:
Role of claudin-2 in Calcium Homeostasis and Kidney Stone Disease
Claudin-2 在钙稳态和肾结石疾病中的作用
- 批准号:
10020951 - 财政年份:2019
- 资助金额:
$ 26.65万 - 项目类别:
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) IV: Prognosis for End-Stage Renal Disease and Biomarker Validation
多囊肾病放射影像研究联盟 (CRISP) IV:终末期肾病的预后和生物标志物验证
- 批准号:
9906761 - 财政年份:2017
- 资助金额:
$ 26.65万 - 项目类别:
CRISP III - Kansas Polycystic Kidney Imaging Program Supplemental Request
CRISP III - 堪萨斯州多囊肾成像计划补充请求
- 批准号:
9269449 - 财政年份:2016
- 资助金额:
$ 26.65万 - 项目类别:
Randomized, controlled pilot study of nicotinamide in polycystic kidney disease
烟酰胺治疗多囊肾病的随机对照试验研究
- 批准号:
8807460 - 财政年份:2015
- 资助金额:
$ 26.65万 - 项目类别:
Randomized, controlled pilot study of nicotinamide in polycystic kidney disease
烟酰胺治疗多囊肾病的随机对照初步研究
- 批准号:
9136856 - 财政年份:2015
- 资助金额:
$ 26.65万 - 项目类别:
Structure-Function Studies of Tight Junction Membrane Proteins
紧密连接膜蛋白的结构-功能研究
- 批准号:
8152114 - 财政年份:2010
- 资助金额:
$ 26.65万 - 项目类别:
相似海外基金
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
- 批准号:
AH/X009637/1 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Research Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
- 批准号:
490127 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Operating Grants
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
- 批准号:
2224295 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Continuing Grant
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
- 批准号:
484618 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Fellowship Programs
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
- 批准号:
23K01937 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
- 批准号:
485670 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
- 批准号:
487847 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
- 批准号:
10064859 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
- 批准号:
480718 - 财政年份:2023
- 资助金额:
$ 26.65万 - 项目类别:
Miscellaneous Programs